ifosfamide has been researched along with Cystadenocarcinoma, Papillary in 2 studies
Cystadenocarcinoma, Papillary: An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ifosfamide has been shown to possess modest activity in patients with platinum/cyclophosphamide refractory ovarian cancer." | 2.69 | Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent. ( Belinson, J; Hurteau, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Sutton, G; Webster, K, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, N | 1 |
| Matsui, H | 1 |
| Nagai, Y | 1 |
| Suzuka, K | 1 |
| Seki, K | 1 |
| Sekiya, S | 1 |
| Markman, M | 1 |
| Kennedy, A | 1 |
| Sutton, G | 1 |
| Hurteau, J | 1 |
| Webster, K | 1 |
| Peterson, G | 1 |
| Kulp, B | 1 |
| Belinson, J | 1 |
1 trial available for ifosfamide and Cystadenocarcinoma, Papillary
| Article | Year |
|---|---|
Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carboplatin; Cisplatin; Cysta | 1998 |
1 other study available for ifosfamide and Cystadenocarcinoma, Papillary
| Article | Year |
|---|---|
Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Antineoplastic Combin | 2002 |